CellAge: Targeting Senescent Cells With Synthetic Biology
Designing better systems for detection and safe removal of dysfunctional “senescent” cells to improve health and treat age-related diseases.
- 171% Funded
- $34,215 Funded
-
campaign
complete
About Mantas Matjusaitis
Mantas Matjusaitis is currently finishing his PhD in synthetic biology (University of Edinburgh, MRC Centre For Regenerative Medicine) and has been involved in the SENS Education programme. He holds a BSc in Biomedical Science, has worked for the global pharmaceutical company AstraZeneca and a number of scientific labs, with topics ranging from nanoparticles to stem cell identity. For the last two years, Mantas was also leading a team of scientists when he was a Vice President and then a President of Innovation Forum Edinburgh branch, an international organization aiming to facilitate collaboration between academics, industry and policy makers.Campaign List
